Tetsuya Ohtaki

Fujisawa, 2518555, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Characterization of NADH-insensitive phosphoribulokinase from a marine, obligately chemolithoautotrophic hydrogen- and sulfur-oxidizing bacterium Hydrogenovibrio marinus MH-110.

Characterization of NADH-insensitive phosphoribulokinase from a marine, obligately chemolithoautotrophic hydrogen- and sulfur-oxidizing bacterium Hydrogenovibrio marinus MH-110.

Journal: Biochemical and biophysical research communications

Published: July 09, 2026

A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation.

A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation.

Journal: Bioorganic & medicinal chemistry letters

Published: August 29, 2017

Highly potent antiobesity effect of a short-length peptide YY analog in mice.

Highly potent antiobesity effect of a short-length peptide YY analog in mice.

Journal: Bioorganic & medicinal chemistry

Published: July 14, 2017

Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.

Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.

Journal: Journal of medicinal chemistry

Published: June 29, 2017

Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.

Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.

Journal: British journal of pharmacology

Published: May 18, 2017

Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.

Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.

Journal: Bioorganic & medicinal chemistry letters

Published: May 09, 2017

A novel LRP1-binding peptide L57 that crosses the blood brain barrier.

A novel LRP1-binding peptide L57 that crosses the blood brain barrier.

Journal: Biochemistry and biophysics reports

Published: April 01, 2017

PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration.

PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration.

Journal: Peptides

Published: February 01, 2017

Antiobesity Effect of a Short-Length Peptide YY Analogue after Continuous Administration in Mice.

Antiobesity Effect of a Short-Length Peptide YY Analogue after Continuous Administration in Mice.

Journal: ACS medicinal chemistry letters

Published: February 01, 2017

A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects.

A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects.

Journal: Bioorganic & medicinal chemistry

Published: January 18, 2017

Generation of a novel artificial TrkB agonist, BM17d99, using T7 phage-displayed random peptide libraries.

Generation of a novel artificial TrkB agonist, BM17d99, using T7 phage-displayed random peptide libraries.

Journal: Biochemical and biophysical research communications

Published: December 21, 2016

Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display.

Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display.

Journal: Biochemical and biophysical research communications

Published: September 27, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026